|
|
Welcome Welcome to the debut issue of MedConnect! MedImpact is pleased to provide you this quarterly newsletter filled with valuable insights and intelligence on pharmacy benefit management and healthcare... read more
|
|
|
|
|
|
Five years into passage of the Affordable Care Act (ACA), what is your general opinion of the ACA? |
|
After responding, if you need to make a change, click here. |
|
|
|
| |
|
MedMatters
MedImpact News
Learn about the hottest news from MedImpact, from announcements to publications to event updates... read more
|
|
|
|
Self-funded
Changing Landscape
In the early part of the decade beginning 2010, employers that self-insured their employee drug benefit were experiencing a relatively calm period. Generic drug prices were flat to declining, lots of brand name blockbuster drugs were ending their patent period... read more
|
|
|
|
Specialty Rx
Biosimilars Update
There has been some attention paid to biosimilars in the past, but now with the FDA's approval of Zarxio as the first biosimilar in the U.S., they are making headlines again. Zarxio is the biosimilar submitted for the brand name Neupogen, which is used to raise white blood... read more
|
|
|
| |
|
MCO Commercial
Hepatitis C
Hepatitis C is an infectious disease affecting primarily the liver, caused by the hepatitis C virus (HCV). The virus was discovered in 1989 and is the most common blood-borne disease in the U.S., with an estimated 3.2 million Americans infected. Sixty to 70%... read more
|
|
|
|
340B
Active Year Ahead
More than two decades ago, Congress enacted the 340B program to enable safety net healthcare organizations to purchase pharmaceuticals at significant discounts and use this benefit to continue their mission of serving more patients and to stretch scarce resources as... read more
|
|
|
|
Drug Info
What to Watch for
In 2014, the FDA Center for Drug Evaluation and Research (CDER) approved an astounding 41 new drugs. The impact of the new Hepatitis C agents, such as Sovaldi and Harvoni, on healthcare spend in 2014 is undeniable. So what can we expect in 2015?... read more
|
|
|
| |
|
Contact Us
We Want Your Input
If you have questions about an article or suggestions for future articles, please contact us... read more
|
|
|
|
Upcoming Events
Visit With Us
MedImpact regularly participates in conferences, tradeshows and other industry events. Learn where we’ll be speaking, attending and exhibiting throughout the year... read more
|
|
|
|
Government
Medicaid Data
The Affordable Care Act (ACA) codified as Public Law 111-148 impacts the delivery of Medicaid healthcare benefits and broadens the scope of eligibility to the Medicaid program. These two aspects of ACA have been well publicized, analyzed, and have a... read more
|
|
|
| | |
|
|
|